{"disease":{"id":"adverse-drug-reaction-adr","name":"adverse drug reaction adr"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06929533","title":"Pharmacogenomics-Supported Psychotropic Prescribing Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Manitoba","has_results":false},{"nct_id":"NCT07063706","title":"Pharmaceutical Care for Patients Using Capecitabine","phase":"NA","overall_status":"COMPLETED","enrollment_count":176,"lead_sponsor_name":"Faculdade de Farmácia","has_results":false},{"nct_id":"NCT07110662","title":"New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}